Journalartikel

Hypoxia-inducible factor-1α activation in HPV-positive head and neck squamous cell carcinoma cell lines


AutorenlisteKnuth, Jennifer; Sharma, Shachi J.; Wuerdemann, Nora; Holler, Claudia; Garvalov, Boyan K.; Acker, Till; Wittekindt, Claus; Wagner, Steffen; Klussmann, Jens P.

Jahr der Veröffentlichung2017

Seiten89681-89691

ZeitschriftOncotarget

Bandnummer8

Heftnummer52

ISSN1949-2553

Open Access StatusGold

DOI Linkhttps://doi.org/10.18632/oncotarget.20813

VerlagImpact Journals


Abstract

Purpose: Human papillomavirus (HPV) is a causative agent for a rising number of head and neck squamous cell carcinomas (HNSCC), which are characterized by distinct tumor biology. Hypoxia inducible-factor (HIF) signaling influences initiation and progression of carcinogenesis and HPV oncoproteins have evolved to highjack cellular pathways for viral reproduction. Therefore, we investigated whether HPV activates HIF-1 alpha expression in HNSCC.

Experimental Technique: HPV-positive and -negative HNSCC cells were examined for adaptive responses to hypoxia. Expression of HIF-1 alpha, prolyl hydroxylasedomain protein 2 (PHD2) and E-cadherin was analyzed by Western blotting, immunofluorescence (IF) microscopy and migration/wound healing assays.

Results: HPV-positive HNSCC cells showed higher HIF-1 alpha and PHD2 protein levels under normoxia and hypoxia. HIF-1 alpha hydroxylation was reduced in HPV-positive HNSCC cell lines under PHD and proteasomal inhibition. In vitro wound healing assays showed impairment of migration and proliferation by HIF-1 alpha pathway activation in HPV-negative cell lines only. In contrast, migration and proliferation in HPV-positive cell lines was impaired by HIF-1 alpha specific siRNA.

Conclusions: HPV-positive HNSCC cells show activation of the HIF pathway and adaptation to HIF-1 alpha upregulation, representing potential therapeutic targets in this emerging tumor entity.




Zitierstile

Harvard-ZitierstilKnuth, J., Sharma, S., Wuerdemann, N., Holler, C., Garvalov, B., Acker, T., et al. (2017) Hypoxia-inducible factor-1α activation in HPV-positive head and neck squamous cell carcinoma cell lines, Oncotarget, 8(52), pp. 89681-89691. https://doi.org/10.18632/oncotarget.20813

APA-ZitierstilKnuth, J., Sharma, S., Wuerdemann, N., Holler, C., Garvalov, B., Acker, T., Wittekindt, C., Wagner, S., & Klussmann, J. (2017). Hypoxia-inducible factor-1α activation in HPV-positive head and neck squamous cell carcinoma cell lines. Oncotarget. 8(52), 89681-89691. https://doi.org/10.18632/oncotarget.20813



Schlagwörter


CANCER-CELLSFEEDBACK REGULATORShead and neck squamous cell carcinoma (hnscc)HIF-1 alphaHuman papillomavirus (HPV)HUMAN-PAPILLOMAVIRUS TYPE-16hypoxia inducible factor-1 alpha (hif-1 alpha)PROGNOSTIC-FACTORprolyl hydroxylase-domain protein 2 (phd2)SOLID TUMORTUMOR-GROWTH


Nachhaltigkeitsbezüge


Zuletzt aktualisiert 2025-10-06 um 10:48